Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe 2023-10-25 21:15
Good Safety Profile and Antitumor Activity: Oral Presentation of Mabwell's 9MW2821 at 2023 ESMO 2023-10-25 17:46
GC Cell Joins U.S Cancer Moonshot Project 2023-10-25 11:27
TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power 2023-10-24 22:31
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO 2023-10-24 21:00
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO 2023-10-24 20:00
Clinical Trial Application (IND) for BioRay Pharmaceutical's BR105 Injection Receives U.S. FDA Approval 2023-10-24 15:05
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC 2023-10-24 09:23
A Safer Tomorrow: AESOP Technology's Battle Against Look-Alike, Sound-Alike Medication Errors 2023-10-24 00:03
Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation 2023-10-23 22:00
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis 2023-10-23 21:30
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain® 2023-10-23 21:00
COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market 2023-10-23 21:00
AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana 2023-10-23 21:00
WAT Medical Donates to the Canadian Red Cross and Peach Arch Hospital 2023-10-23 21:00
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day 2023-10-23 20:00
Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC 2023-10-23 19:56
Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs 2023-10-23 18:25
JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval 2023-10-23 18:01
1 68 69 70 71 72 800